Fei Mingming, Li Ping, Tao Xiaogen, Pan Aijun, Wang Jinquan
Department of Intensive Care Medicine, the First Affiliated Hospital of the University of Science and Technology of China, Hefei 230001, Anhui, China. Corresponding author: Tao Xiaogen, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Apr;31(4):418-421. doi: 10.3760/cma.j.issn.2095-4352.2019.04.009.
To investigate the effect of serum calcium level on the prognosis of patients with sepsis.
Clinical data of 119 patients with sepsis admitted to intensive care medicine (ICU) of the First Affiliated Hospital of the University of Science and Technology of China from January 2017 to October 2018 were retrospectively analyzed. Gender, age, and C-reactive protein (CRP), procalcitonin (PCT), serum calcium levels, acute physiology and chronic health evaluation II (APACHE II), sequential organ failure score (SOFA) within 24 hours of diagnosis, and 28-day mortality were collected. The patients were divided into the normal serum calcium group (serum calcium 2.00-2.67 mmol/L) and the hypocalcemia group (serum calcium < 2.00 mmol/L) according to their serum calcium level. The patients were divided into survival group and death group according to 28-day prognosis. Pearson correlation test was used to analyze the correlation between serum calcium level and clinical indicators. Receiver operator characteristic (ROC) curve was used to analyze the predictive value of serum calcium level on prognosis.
A total of 119 patients with sepsis were included, including 50 patients with normal serum calcium, with serum calcium level of (2.14±0.10) mmol/L; and 69 patients of hypocalcemia, and the incidence of hypocalcemia was 57.98%, with serum calcium level of (1.81±0.14) mmol/L. In the hypocalcemia group, except that the APACHE II score was significantly higher than that of the normal serum calcium group (25.59±5.52 vs. 22.28±4.89, P < 0.01), there was no significant difference in gender, age, CRP, PCT and SOFA score between the two groups. The 28-day mortality rate of the hypocalcemia group was significantly higher than that of the normal serum calcium group [78.26% (54/69) vs. 48.00% (24/50), χ = 10.45, P < 0.01]. The level of serum calcium in the death group was significantly lower than that in the survival group (mmol/L: 1.90±0.20 vs. 2.04±0.19), while the APACHE II score was significantly higher than the survival group (25.78±5.25 vs. 21.20±4.68), with statistically significant differences (both P < 0.01). There was a negative correlation between serum calcium level and PCT, APACHE II scores in patients with sepsis (r = -2.10, P = 0.04; r = -3.91, P < 0.01), but no correlation with CRP and SOFA score (r = 0.75, P = 0.46; r = -1.21, P = 0.23). The ROC curve analysis showed that the area under the ROC curve (AUC) for predicting the prognosis of sepsis patients with serum calcium level was 0.70 [95% confidence interval (95%CI) = 0.602-0.798], and the best cut-off value was 1.92 mmol/L, with the sensitivity was 52.56%, and the specificity was 82.93%.
The prognosis of sepsis patients with hypocalcemia is poor. Serum calcium level can be used as a predictor of prognosis in patients with sepsis.
探讨血清钙水平对脓毒症患者预后的影响。
回顾性分析2017年1月至2018年10月在中国科学技术大学附属第一医院重症医学科(ICU)收治的119例脓毒症患者的临床资料。收集患者的性别、年龄、C反应蛋白(CRP)、降钙素原(PCT)、血清钙水平、诊断后24小时内的急性生理与慢性健康状况评分系统II(APACHE II)、序贯器官衰竭评分(SOFA)以及28天死亡率。根据血清钙水平将患者分为正常血清钙组(血清钙2.00 - 2.67 mmol/L)和低钙血症组(血清钙<2.00 mmol/L)。根据28天预后将患者分为生存组和死亡组。采用Pearson相关性检验分析血清钙水平与临床指标之间的相关性。采用受试者工作特征(ROC)曲线分析血清钙水平对预后的预测价值。
共纳入119例脓毒症患者,其中血清钙正常患者50例,血清钙水平为(2.14±0.10)mmol/L;低钙血症患者69例,低钙血症发生率为57.98%,血清钙水平为(1.81±0.14)mmol/L。低钙血症组中,除APACHE II评分显著高于正常血清钙组(25.59±5.52比22.28±4.89,P<0.01)外,两组在性别、年龄、CRP、PCT及SOFA评分方面差异无统计学意义。低钙血症组28天死亡率显著高于正常血清钙组[78.26%(54/69)比48.00%(24/50),χ² = 10.45,P<0.01]。死亡组血清钙水平显著低于生存组(mmol/L:1.90±0.20比2.04±0.19),而APACHE II评分显著高于生存组(25.78±5.25比21.20±4.68),差异均有统计学意义(均P<0.01)。脓毒症患者血清钙水平与PCT、APACHE II评分呈负相关(r = -2.10,P = 0.04;r = -3.91,P<0.01),但与CRP和SOFA评分无相关性(r = 0.75,P = 0.46;r = -1.21,P = 0.23)。ROC曲线分析显示,血清钙水平预测脓毒症患者预后的ROC曲线下面积(AUC)为0.70[95%置信区间(95%CI)= 0.602 - 0.798],最佳截断值为1.92 mmol/L,灵敏度为52.56%,特异度为82.93%。
低钙血症的脓毒症患者预后较差。血清钙水平可作为脓毒症患者预后的预测指标。